| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06840496 | To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in… | Rett Syndrome | Recruiting | 2026-03-27 |
| Phase 2 | ||||
| NCT06732245 | Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese | Obesity and Overweight | Not Yet Recruiting | 2026-03-27 |
Obesity (1)